Em Empowering H Health th Supporting Innovation Dr r Nic Nic - - PowerPoint PPT Presentation

Em Empowering H Health th

Supporting Innovation

Dr r Nic Nic Woods

Health Lead, Microsoft Australia

A little about me

• Assoc. Professor Jared Dart

BSc BA (Econ, Govt) M.B.B.S. PhD (eHealth, Medicine) FRACGP Chief Medical Officer

• Passionate about solving complex problems for the benefit of

society and individuals

Primary Care

The Centre of the Universe

• 130MM consults
• 26,000 GPs $10.4B
• <25 years = 21.1%
• 25-44 years = 22.9%
• 45 – 64 = 28.2%
• 65+ years = 27.8%
• 40%+ chronic conditions

GENERAL PRACTICE

HOSPITAL AND ACUTE

SPECIALIST PHARMACY

• 19,000 Pharmacists
• $18Bn
• 270MM prescriptions
• 25,400 specialists
• 9.3MM Admissions
• Emergency 6.5MM
• 1/5 Admitted

Referral 54/100 Referral 8.1/100 Discharge ~100% Referral 0.3/100 Discharge ~100%

Old News

• Telehealth is not new, nor

even recent

Th The Radio Doctor

April, 1924, Radio News Magazine

‘Virtual’ care

• Seems to suggest exclusion of

the HCP

• ‘Technology enhanced care’

may be more appropriate

Di Diagnosis b by R Radio

February, 1925, Science and Invention magazine

Furious Agreement

eHealth has POTENTIAL TO IMPROVE HEALTH OUTCOMES AT ALL LEVELS from preventative health, specialist and acute care and self-management

• f chronic conditions, through to

home monitoring for people living with disabilities The POTENTIAL FOR NEW INITIATIVES IN THE TELEHEALTH ARENA IS VAST as is the potential for enabling patients with special needs (such as the elderly or those with limited mobility) to gain better access to primary healthcare Using TELEHEALTH TECHNOLOGY to help the chronically ill to monitor and manage their condition at home could almost halve mortality rates and save the health budget up to $3 billion a year

A little about Welio

In In 2016 We Welio partnered with Micr crosoft to co-de develop a p a v virt rtua ual c care pl platform rm f for he r health c h care pr professiona nals, g , given; n; 1. technology based patient consultations are already occurring but in a sub-optimal fashion

• security/privacy is adhoc and not at global HIPAA standard
• cost-recoverability and chargeability substandard
• clinician-driven, patient-centric additional functions (e.g self-directed care) lacking

2. these are soluble issues which if addressed can enhance both clinical and commercial outcomes

The ‘We’ in Welio

Collaboration will drive clinical uptake so everyone is invited. Have (and will continue to) taken input from ecosystem stakeholders;

• Practices – doctor owned, small group practice, corporate practices
• Health Insurers
• Medical indemnity provider
• Peak representative bodies including AMA, RACGP, ACRRM, RANZCP, APA and others
• Government
• Academia
• The broader eHealth industry

Research: GPs and TBPC

Survey via The Medical Republic N= 97 on Technology Based Patient Consultations (TBPC), Welio and how/where it can add value.

‘patient consultations that use any form of technology, including, but not restricted to videoconferencing, internet and telephone, as an alternative to face-to-face consultations

Me Medical Board of Australia

Current use of TBPC

Current use of TBPC (any form)

66%

Use of Live Video (unsecured)

28%

Could have used Welio

(%age of last 100 patients)

0% 5% 10% 15% 20% 25% 30% 35% 40% MORE THAN 20% 10-20% UP TO 10%

Of your last 100 patients, what proportion could have been conducted via Welio?

Source: TMR GP Survey (n=97)

GP Interest rates 8 out of 10

• 43% of GPs rate their level of interest

between 8 and 10 on a 10 point scale.

• Regardless of city or rural

How secure is it really?

• Concern for liability
• Welio is HIPAA compliant;

highest level of security possible, unprecedented in Australia

Majority of clinicians rate security as mission-critical

Above all do no harm

• Concern for going beyond clinical remit
• verextending
• Concern for liability
• Welio initial use in chronic disease follow

up

• Use is covered under professional

indemnity insurance

Clinican concerns around use of virtual care relate to missing something (in the absence of physical exam)

Not relevant to all consults

• Welio is designed for use by the patients usual practice

and ideally their usual GP

• In some situations there is no substitute for an in-person

consultation and video consultations should be avoided.

• New patients that the HCP doesn’t know and can’t

examine

• New symptoms in existing patients that require a physical

examination

Welio will augment but cannot replace HCP

Future functionality

• Activate self-directed care kits developed by

independent, credible peak bodies nationwide

• Monitor biometric data from compatible mHealth

devices

• Instantly message patients and care team members
• Generate evidence-based chronic disease

management plans with a single touch

• Seamlessly connect and refer patients for speciality

consultations

To be deployed if our pilot HCPs see value

Where to next?

• Artificial intelligence
• Bots
• Deep and predictive learning
• Mixed reality

AI. We have the technology. Utility needs to be determined

Introducing

nationwide piloting

Independent validation via academic partner

Pilot and development program

Objectives of the Welio pilot and development program are:

Implementation and feasibility

To ensure / demonstrate that Welio integrates seamlessly into the clinical processes currently employed by GPs

Acceptability and Effectiveness

To demonstrate the effectiveness of Welio Consultation in the real world

a. Demonstrate that Welio consultations are not inferior to a face to face consultation b. Identify the circumstances where Welio consultations are superior to a face to face consultation

Want to help shape the future of virtual care?

HCPs and related

• rganisations can register at

welio.com